US FDA approves two gene therapies for sickle cell disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/30/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. ULTA
8. NVDA
9. GAP
10. DG

Go back to US FDA approves two gene therapies for sickle cell disease
BLUEBIRD BIO (NASDAQ: BLUE) Delayed: 4.97 --0 (-0%)
Previous Close $4.97    52 Week High $95.28 
Open $4.97    52 Week Low $35.37 
Day High $4.97    P/E N/A 
Day Low $4.97    EPS $-1.81 
Volume 2,124,984       

(NASDAQ: CRSP) Delayed: 57.72 -1.65 (2.78%)
Previous Close $59.37    52 Week High $18.88 
Open $58.22    52 Week Low $13.75 
Day High $59.37    P/E N/A 
Day Low $57.10    EPS $0.00 
Volume 1,388,433       

Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Delayed: 541.69 -5.86 (1.07%)
Previous Close $547.55    52 Week High $134.71 
Open $547.09    52 Week Low $73.31 
Day High $549.57    P/E N/A 
Day Low $540.08    EPS $-1.98 
Volume 886,913